Picture of Bionik Laboratories logo

BNKL Bionik Laboratories Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Bionik Laboratories, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-14.6-10.6-25-13.6-10.4
Depreciation
Amortisation
Non-Cash Items6.382.4616.18.416.02
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.123-1.49-0.5710.3990.14
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-7.71-9.23-9.06-4.62-4.15
Capital Expenditures-0.022-0.102-0.160-0.013
Purchase of Fixed Assets
Cash from Investing Activities-0.022-0.102-0.160-0.013
Financing Cash Flow Items0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7.79.27112.965.55
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.036-0.0611.82-1.661.38

Or unlock with your email

Or unlock with your email